Skip to main content
Fig. 7 | BMC Medical Genomics

Fig. 7

From: Role of ATF3 as a prognostic biomarker and correlation of ATF3 expression with macrophage infiltration in hepatocellular carcinoma

Fig. 7

Correlation of ATF3 expression with markers of immune cells in HCC. Correlations between ATF3 and a CD8 + T cell markers (CD8A and CD8B); b T cell (general) markers (CD3D and CD3E); c B cell markers (CD19 and CD79A); d Monocyte markers (CD86 and CSF1R); e TAM markers (CCL2 and CD68); f M1 macrophage markers (NOS2 and IRF5); g M2 macrophage markers (CD163 and VSIG4); h Neutrophil markers (ITGAM and CCR7); i NK cell markers (KIR2DL1 and KIR2DL3); j Dendritic cell markers (HLA-DPB1 and HLA-DQB1); k Th1 cell markers (TBX21 and STAT4); l Th2 cell markers (GATA3 and IL13); m Tfh cell markers (BCL6 and IL21); n Th17 cell markers (STAT3 and IL17A); o Treg cell markers (Foxp3 and TGFB1); p T cell exhaustion markers (PDCD1, CTLA4, LAG3, and GZMB). Purity, correlation adjusted by purity. *P < 0.01; **P < 0.001; ***P < 0.0001

Back to article page

BMC Medical Genomics

ISSN: 1755-8794

Contact us